Literature DB >> 22576022

Prevalence of infections in long-term care facilities: how to read it?

M Marchi1, E Grilli, M Mongardi, C Bedosti, L Nobilio, M L Moro.   

Abstract

PURPOSE: Prevalence surveys are mostly used in European countries for infection surveillance in long-term care facilities (LTCFs). The purpose of this paper is to document the prevalence of infections in LTCFs and to identify and discuss the potential sources of variation in the overall prevalence of infections.
METHODS: Six repeated prevalence surveys were carried out over a period of 3 years in 11 LTCFs in the Emilia-Romagna region, involving a mean of 812 residents in each survey. In one facility, continuous surveillance was also conducted. McGeer's infection criteria were used. Observers undertook a 1-day training course and on-field training.
RESULTS: The average prevalence of infected residents was 11.5/100 residents: respiratory tract infections were the most common (5.7/100 residents), followed by urinary tract infections (2.6%), skin infections (1.9%), and ocular infections (1.4%). In a multivariate model, the prevalence significantly varied by season (p < 0.001) and residents' case-mix index (CMI, p < 0.001). In individual homes, the case mix varied from 0.91 to 1.1 and the observed prevalence varied from 6.6 to 40.4%. One facility set up and maintained continuous surveillance: three clusters of lower respiratory tract infection were identified in 1.5 years by a temporal scan test. Cases belonging to one outbreak only were captured by the prevalence surveys conducted in the same periods.
CONCLUSIONS: The prevalence of infections in LTCFs needs to be interpreted cautiously, given the effects of seasonality and case-mix variation. Repeated prevalence surveys may be a good start in individual facilities, but the identification of outbreaks requires a continuous surveillance system.

Entities:  

Mesh:

Year:  2012        PMID: 22576022     DOI: 10.1007/s15010-012-0266-1

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Infectious disease outbreaks in nursing homes: an unappreciated hazard for frail elderly persons.

Authors:  Larry J Strausbaugh; Shirin R Sukumar; Carol L Joseph
Journal:  Clin Infect Dis       Date:  2003-03-19       Impact factor: 9.079

2.  The burden of healthcare‐associated infections in European long‐term care facilities.

Authors:  M L Moro; B Jans; B Cookson; J Fabry
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

3.  Longitudinal trends in antibiotic resistance in US nursing homes, 2000-2004.

Authors:  Christopher J Crnich; Nasia Safdar; Jim Robinson; David Zimmerman
Journal:  Infect Control Hosp Epidemiol       Date:  2007-06-22       Impact factor: 3.254

4.  Definitions of infection for surveillance in long-term care facilities.

Authors:  A McGeer; B Campbell; T G Emori; W J Hierholzer; M M Jackson; L E Nicolle; C Peppler; A Rivera; D G Schollenberger; A E Simor
Journal:  Am J Infect Control       Date:  1991-02       Impact factor: 2.918

5.  Standardized infection surveillance in long-term care: interfacility comparisons from a regional cohort of facilities.

Authors:  Kurt B Stevenson; James Moore; Holly Colwell; Barbara Sleeper
Journal:  Infect Control Hosp Epidemiol       Date:  2005-03       Impact factor: 3.254

6.  Refining a case-mix measure for nursing homes: Resource Utilization Groups (RUG-III).

Authors:  B E Fries; D P Schneider; W J Foley; M Gavazzi; R Burke; E Cornelius
Journal:  Med Care       Date:  1994-07       Impact factor: 2.983

7.  SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.

Authors:  Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

8.  Infection surveillance and control programs in the Department of Veterans Affairs nursing home care units: a preliminary assessment.

Authors:  Linda Tsan; Christa Hojlo; Martha A Kearns; Chester Davis; Robert Langberg; Maurice Claggett; Nancy Coughlin; Michael Miller; Robert Gaynes; Cynthia Gibert; Ona Montgomery; Chesley Richards; Linda Danko; Gary Roselle
Journal:  Am J Infect Control       Date:  2006-03       Impact factor: 2.918

  8 in total
  6 in total

Review 1.  Topical negative pressure to treat surgical site infections, with a focus on post-sternotomy infections: a systematic review and meta-analysis.

Authors:  A Pan; G De Angelis; E Nicastri; G Sganga; E Tacconelli
Journal:  Infection       Date:  2013-10-05       Impact factor: 3.553

2.  Antimicrobial prescribing in nursing homes in Finland: results of three point prevalence surveys.

Authors:  M-L Rummukainen; T Kärki; M Kanerva; M Haapasaari; J Ollgren; O Lyytikäinen
Journal:  Infection       Date:  2012-09-17       Impact factor: 3.553

3.  Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.

Authors:  S Shilo; M V Assous; T Lachish; P Kopuit; T Bdolah-Abram; A M Yinnon; Y Wiener-Well
Journal:  Infection       Date:  2012-12-28       Impact factor: 3.553

4.  Use of hand hygiene agents as a surrogate marker of compliance in Hungarian long-term care facilities: first nationwide survey.

Authors:  Rita Szabó; Júlia Morvai; Fernando Bellissimo-Rodrigues; Didier Pittet
Journal:  Antimicrob Resist Infect Control       Date:  2015-07-31       Impact factor: 4.887

Review 5.  Reducing inappropriate antibiotic prescribing in the residential care setting: current perspectives.

Authors:  Ching Jou Lim; David C M Kong; Rhonda L Stuart
Journal:  Clin Interv Aging       Date:  2014-01-13       Impact factor: 4.458

6.  Antimicrobial prescribing in long-term care facilities: a nationwide point-prevalence study, Slovenia, 2016.

Authors:  Dora Stepan; Lea Ušaj; Marija Petek Šter; Marjetka Smolinger Galun; Hermina Smole; Bojana Beović
Journal:  Euro Surveill       Date:  2018-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.